Kevin Lösch

Building...

📍 Other🔄 Updated September 2026💼 7 investments📅 5 years investing🗓 Last invested Jan 2025
VC🌍 Other
7
Total investments
2
Early stage
1
Mid stage
1
Late stage
5y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Member
Jan 2025
At Samphire Neuroscience, were on a mission to transform womens health through brain based innovation. Our vision is simple: to create a world where women have access to medical grade solutions that empower them to take control of their health—without compromising on technology, design, or lifestyle. Building on over 30 years of research and clinical expertise, we’ve developed Nettle, the worlds first brain stimulating headband for the at-home alleviation of PMS and period pain symptoms. Samphire Neuroscience also offers neuroscience-backed cycle tracking via the Samphire app, available on the Apple App Store and Google Play.
Investor & Board Member
Jan 2024
Biomatter is an enzyme design company creating previously impossible enzymes for health and sustainable manufacturing applications. We partner with leading companies across food, chemicals, home care, agriculture, diagnostics, and therapeutics to deliver new enzyme molecules — designed with AI and Physics, built and tested in our lab, in weeks rather than years.
Investor
Dec 2022
toddle is a visual programming platform for building modern web applications without the need for writing code.
Investor & Board Member
Sep 2022
Medoma offers a care orchestration platform for hospital-level care in the home
Investor & Board Observer
Jun 2022
Building the future of music rights investments with an open standard for valuations, transactions, and royalty data, offering access to the worlds most exclusive music rights.
Investor & Board Observer
Mar 2022
Your way to effortless payment splitting. Our goal at Anyday is to create a save, flexible and easy way for you to pay for your expenses. And best of all, its completely free! Thats right, no hidden charges, no sneaky interest rates, only easy slicing solutions. What you see is exactly what you get. Our mission is to flip the script on payments. We get it - partial payment has not always had the best reputation and can sound sketchy but were here to make a positive change. Our guiding principles are simple: fairness, decency, and transparency. Are you ready to provide your customers with a payment option thats fair and crystal clear? Are you curious to learn more about us, our values, and the fantastic partners we collaborate with? Contact us! Anyday.io Instagram.dk/anyday_dk Facebook.dk/anyday.io
Experience · 8 entries
All (8)
Investments (7)
Founder (1)
Board (5)
2025
Investor & Board Member
Jan 2025
At Samphire Neuroscience, were on a mission to transform womens health through brain based innovation. Our vision is simple: to create a world where women have access to medical grade solutions that empower them to take control of their health—without compromising on technology, design, or lifestyle. Building on over 30 years of research and clinical expertise, we’ve developed Nettle, the worlds first brain stimulating headband for the at-home alleviation of PMS and period pain symptoms. Samphire Neuroscience also offers neuroscience-backed cycle tracking via the Samphire app, available on the Apple App Store and Google Play.
2024
Investor & Board Member
Jan 2024
Biomatter is an enzyme design company creating previously impossible enzymes for health and sustainable manufacturing applications. We partner with leading companies across food, chemicals, home care, agriculture, diagnostics, and therapeutics to deliver new enzyme molecules — designed with AI and Physics, built and tested in our lab, in weeks rather than years.
2022
Investor
Dec 2022
toddle is a visual programming platform for building modern web applications without the need for writing code.
Investor & Board Member
Sep 2022
Medoma offers a care orchestration platform for hospital-level care in the home
Investor & Board Observer
Jun 2022
Building the future of music rights investments with an open standard for valuations, transactions, and royalty data, offering access to the worlds most exclusive music rights.
Show all 8 entries ↓
Investment activity
2021–2025 · 7 investments
20211202242024120251
Recent (last 2 years)Earlier